Catheterization Lab Equipment in Maryland

Elutia Inc. is a medical device company specializing in proprietary drug-eluting biomaterial platforms designed to enhance surgical reconstruction and cardiovascular repair. The company develops next-generation allograft and extracellular matrix products that integrate biologic materials with extended antibiotic release capabilities, addressing post-surgical complications and improving patient outcomes in reconstructive and cardiovascular procedures. Core product lines include SIMPLIDERM, a high-performance allograft for soft tissue reconstruction; PROXICOR PC and PROXICOR CTR engineered extracellular matrices for cardiovascular repair; VASCURE for vascular applications; and TYKE for pediatric cardiovascular use. Elutia's platform enables surgeons to perform complex reconstructive procedures using natural, regenerative materials while leveraging controlled drug delivery to reduce infection risk and optimize healing. The company positions itself at the intersection of drugs, devices, and biomatrices, focusing on solving challenges inherent to traditional medical implants through biocompatible design. Founded by C. Randal Mills, PhD., Elutia operates from Gaithersburg, Maryland, and engages in direct surgeon and institution outreach through digital education webinars and sales representative networks. The company's approach emphasizes patient-centric outcomes and long-term tissue remodeling rather than purely synthetic alternatives.

Terumo Medical Corporation (North America division of Terumo Corporation, founded 1921) is a global leader in medical devices and supplies, headquartered in Somerset, NJ, with manufacturing operations in Elkton, MD and Caguas, PR. The company operates in 160 countries with 2,000+ North American associates supporting 30,000+ global employees. Terumo Medical manufactures injection and infusion therapy devices, safety syringes (including the SurTract™ Safety Syringe with SafeR® passive safety technology), and related products for human and animal health markets. The Terumo Interventional Systems (TIS) division specializes in minimally invasive solutions for cardiology, peripheral arterial disease, embolotherapy, and interventional oncology, providing entry site management, lesion access, and therapeutic intervention devices. Terumo Health Outcomes (THO) delivers operational and clinical decision support to hospitals and clinicians. The Pharmaceutical Solutions Division (PSD) provides design and development services. Terumo performs integrated R&D, manufacturing, marketing, distribution, and sales. The company is recognized as one of the world's leading medical device manufacturers, serving diverse healthcare markets with a focus on quality, innovation, and patient outcomes.

Terumo Cardiovascular Systems Corp. is a leading manufacturer of cardiopulmonary bypass and perfusion equipment, specializing in oxygenators, heart-lung machines, blood gas monitoring systems, and endoscopic vessel harvesting (EVH) products for cardiac surgery. The company manufactures the world's longest-running line of commercially available heart-lung machines and pioneered the first hollow fiber oxygenator technology. Terumo's product portfolio includes advanced perfusion systems, continuous in-line blood gas monitors (CDI Systems), and specialized surgical instruments for coronary artery bypass grafting (CABG) procedures. Their CDI OneView monitoring system provides real-time monitoring of up to 22 vital patient parameters, serving as an industry benchmark for perfusion management. The company serves cardiac operating rooms, perfusion departments, and cardiovascular surgical centers across North America and internationally. Terumo emphasizes quality systems management, clinical outcomes optimization, and training for perfusionists and cardiac surgeons. The company provides educational webinars, expert guidance on EVH techniques, and perfusion management resources to support clinicians at all experience levels.